Authors: Lucock, M Daskalakis, I Hinkins, M Yates, Z

Citation: M. Lucock et al., An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy, MOL GEN MET, 73(4), 2001, pp. 322-332

Authors: Lucock, M Daskalakis, I Briggs, D Yates, Z Levene, M

Citation: M. Lucock et al., Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: Influence of 677c -> t methylenetetrahydrofolate reductaseand 2756a -> g methionine synthase genotypes, MOL GEN MET, 70(1), 2000, pp. 27-44

Authors: Lucock, M Daskalakis, I

Citation: M. Lucock et I. Daskalakis, New perspectives on folate status: a differential role for the vitamin in cardiovascular disease, birth defects and other conditions, BR J BIOMED, 57(3), 2000, pp. 254-260

Authors: Lucock, MD Daskalakis, I Schorah, CJ Lumb, CH Oliver, M Devitt, H Wild, J Dowell, AC Levene, MI

Citation: Md. Lucock et al., Folate-homocysteine interrelations: Potential new markers of folate status, MOL GEN MET, 67(1), 1999, pp. 23-35

Authors: Guerrero, RAA Amuchastegui, M Badaracco, J Elizari, M Martellotto, R De la Hoz, RP Ramos, JL Salvati, AM Sinisi, A Torre, H Aroney, G Campbell, T Garrahy, P",Lalman,"Liebens, I Renard, M Bastecky, J Bocek, P Cepelak, V Dvorak, K Gregor, J Janousek, S Jansky, P Jirmar, R Kamenik, L Rybka, J Spacek, R Spinar, J Svitil, P Zeman, K Alagha, Z Allam, S Barnay, C Baudouy, M Beltran, J Berland, J Berthou, JD Bery, E Bessede, G Beygui, F Bickert, P Boshat, J Boulenc, JM Bourlard, P Bouthillier, D Brandt, C Cattan, S Charbonnier, B Citron, B Coisne, D Coupillaud, J Da Costa, A Dambrine, P Danchin, N Delarche, N Dequeker, JL Desjouaux, E Dievart, F Dujardin, JJ Durand, P Fadel, N Fichter, P Galinier, M Gryman, R Gauthier, J Geslin, P Godard, S Grollier, G Guerot, C Gully, C Janin-Manificat, L Joly, P Joseph, T Juillard, A Ketelers, JY Lagorce, P Laine, E Lang, M Lanney-Courten, JE Le Helloco, A Ledru, F Levy, S Litvine-Itaya, L Lopez, M Mansour, M Mathurin, C Meyer, G Mossaz, R Nedelec, G Ollitrault, J Pacouret, G Perchet, H Poitrineau, O Richard, M Rocher, R Rougier, L Sagnol, P Tardieu, A Thery, C Thieuleux, F Touboul, P Tran-Tanh, X Veyrat, A Villarem, D Werquin, S Skoufas, P Fotiadis, I Xenodochidis, C Karidis, K Limberi, S Papasteriadis, E Giokas, K Kremastinos, D Polichronaki, E Moshos, N Daskalakis, I Janecsko, M Janosi, A Kalo, E Karpati, P Mezofi, M Nyaradi, A Ofner, P Oze, B Poor, F Preda, I Ronaszeki, A Valyi, P Zamolyi, K Davini, P Martines, C Melandri, F Pasotti, C Pettinati, G Veze, I Kochkarev, F Erpelding, J Halaczkiewicz, H Ilmuzynska, K Kurowski, M Lasota-Czopnik, A Markiewicz, M Musial, W Nartowicz, E Pasyk, S Prastowski, W Ruszkowski, J Sadowski, Z Sas, M Stopinski, M Ujda, M Wojciechowski, D Diniz, M Drumond, A Rodrigues, P Pereira, MA Correia, A Scherbak, A Irklienko, K Dudko, L Goloschekin, B Maximova, G Sorokin, L Inyushin, A Bzhelianskaia, V Kostenko, V Stefanenko, M Bilich, A Froufe, G Masip, J Pajaron, A Roura, J Sanz, G Valle, V Caduff, B Moccetti, T Noseda, G Simonin, C Baars, HF Bernink, PJLM Daniels, MCG Gobel, E Nagelsmit, MJ Ramdat, AR Senden, PJ van Rossum, P van Wijk, LM Withagen, AJAM Crowe, PF Davidson, C Handler, CE",McNeil,"Molajo, AO

Citation: Raa. Guerrero et al., Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS (FRAxiparine in Ischaemic Syndrome), EUR HEART J, 20(21), 1999, pp. 1553-1562